Cite

HARVARD Citation

    Pan, C. et al. (2020). An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Molecular oncology. 14 (8), pp. 1800-1816. [Online]. 
  
Back to record